HOXA9 regulates angiogenesis in human hypertrophic scars: induction of VEGF secretion by epidermal stem cells

Peng-Fei Cao; Ying-Bin Xu; Jin-Ming Tang; Rong-Hua Yang; Xu-Sheng Liu
June 2014
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 6, p2998
Academic Journal
No abstract available.


Related Articles

  • Investigating the Role of P311 in the Hypertrophic Scar. Jianglin Tan; Xu Peng; Gaoxing Luo; Bing Ma; Chuan Cao; Weifeng He; Shunzong Yuan; Shirong Li; Wilkins, John A.; Jun Wu // PLoS ONE;2010, Vol. 5 Issue 4, p1 

    The mechanisms of hypertrophic scar formation are not fully understood. We previously screened the differentially expressed genes of human hypertrophic scar tissue and identified P311 gene as upregulated. As the activities of P311 in human fibroblast function are unknown, we examined the...

  • Keratinocyte-Derived Vascular Permeability Factor (Vascular Endothelial Growth Factor) Is a Potent Mitogen for Dermal Microvascular Endothelial Cells. Detmar, Michael; Yeo, Kiang-Teck; Nagy, Janice A.; van de Water, Livingston; Brown, Lawrence F.; Berse, Brygida; Elicker, Brett M.; Ledbetter, Stephen; Dvorak, Harold F. // Journal of Investigative Dermatology;Jul95, Vol. 105 Issue 1, p44 

    Expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is markedly increased in the epidermis of lesional psoriatic skin and in healing skin wounds. In this study, we characterized the effects of several cytokines and growth factors on the expression and...

  • Multiple Roles for VEGF in Non-Melanoma Skin Cancer: Angiogenesis and Beyond. Johnson, Kelly E.; Wilgus, Traci A. // Journal of Skin Cancer;2012, p1 

    Vascular endothelial growth factor (VEGF) is known to play a critical role in the development of non-melanoma skin cancers. VEGF is a potent pro-angiogenic factor and it is elevated in mouse and human skin tumors. The use of transgenic and knockout mice has shown that VEGF is essential for tumor...

  • Hypoxia Regulates the Expression of Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) and its Receptors in Human Skin. Detmar, Michael; Brown, Lawrence F.; Berse, Brygida; Jackman, Robert W.; Elicker, Brett M.; Dvorak, Harold F.; Claffey, Kevin P. // Journal of Investigative Dermatology;Mar1997, Vol. 108 Issue 3, p263 

    Tissue hypoxia is a characteristic feature of malignant tumors and healing wounds, conditions that are associated with angiogenesis and with increased expression of vascular permeability factor (VPF; also called vascular endothelial growth factor, VEGF), a selective endothelial cell mitogen...

  • KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells. Wang, Yinan; Yang, Chuanhe; Gu, Qingqing; Sims, Michelle; Gu, Weiwang; Pfeffer, Lawrence M.; Yue, Junming // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    The transcription factor Krüppel-like factor 4 (KLF4) has been implicated in regulating cell proliferation, migration and differentiation in a variety of human cells and is one of four factors required for the induction of pluripotent stem cell reprogramming. However, its role has not been...

  • The role of VEGF in normal and neoplastic hematopoiesis. Gerber, Hans-Peter; Ferrara, Napoleone // Journal of Molecular Medicine;Jan2003, Vol. 81 Issue 1, p20 

    VEGF is a secreted growth factor that mediates its biological effects by binding to two transmembrane tyrosine kinase receptors, VEGFR-1 and VEGFR-2. The VEGF/receptor signaling system is involved in the regulation of two fundamental processes in vertebrates: the formation of blood vessels...

  • MicroRNA-378 Promotes Osteogenesis-Angiogenesis Coupling in BMMSCs for Potential Bone Regeneration. Zhang, Bo; Li, Yali; Yu, Yang; Zhao, Jinlong; Ou, Yangzhen; Chao, Yu; Yang, Binhui; Yu, Xiaorui // Analytical Cellular Pathology: Cellular Oncology;3/1/2018, p1 

    Bone tissue regeneration was closely associated with osteogenesis and angiogenesis. The harmonious regulation of osteogenetic and angiogenic growth factors would enhance bone regeneration, while the imbalance of that would lead to local excessive bone formation or vascular mass due to exogenous...

  • The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A. Dedieu, S.; Canron, X.; Rezvani, H. R.; Bouchecareilh, M.; Mazurier, F.; Sinisi, R.; Zanda, M.; Moenner, M.; Bikfalvi, A.; North, S. // BMC Medicine;2010, Vol. 8, p19 

    Background: Amifostine (WR-2721, delivered as Ethyol® is a phosphorylated aminothiol compound clinically used in addition to cis-platinum to reduce the toxic side effects of therapeutic treatment on normal cells without reducing their efficacy on tumour cells. Its mechanism of action is...

  • HIV Protease Inhibitors Decrease VEGF/HIF-1α Expression and Angiogenesis in Glioblastoma Cells. Pore, Nabendu; Gupta, Anjali K.; Cerniglia, George J.; Maity, Amit // Neoplasia;Nov2006, Vol. 8 Issue 11, p889 

    Glioblastomas are malignant brain tumors that are rarely curable, even with aggressive therapy (surgery, chemotherapy, and radiation). Glioblastomas frequently display loss of PTEN and/or epidermal growth factor receptor activation, both of which activate the PI3K pathway. This pathway can...

  • Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Funahashi, Yasuhiro; Shawber, Carrie J.; Sharma, Anshula; Kanamaru, Emi; Choi, Yun K.; Kitajewski, Jan // Vascular Cell;Jan2011, Vol. 3, p1 

    Background: In the vasculature, Notch signaling functions as a downstream effecter of Vascular Endothelial Growth Factor (VEGF) signaling. VEGF regulates sprouting angiogenesis in part by inducing and activating matrix metalloproteases (MMPs). This study sought to determine if VEGF regulation of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics